Eyepoint Inc (EYPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EYPT | AZN | AMGN | GILD | BMY |
| Company | Eyepoint Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 17.18 | 205.64 | 388.00 | 147.87 | 62.37 |
| High | 18.30 | 206.30 | 391.29 | 150.20 | 62.89 |
| Low | 16.92 | 203.34 | 383.65 | 147.80 | 62.21 |
| Latest | 18.54 | 204.13 | 384.71 | 149.01 | 62.50 |
| Change | +0.98 | -4.32 | -3.45 | +0.06 | +0.13 |
| % Change | +5.58% | -2.07% | -0.89% | +0.04% | +0.21% |
| Volume | 376,728 | 852,653 | 770,987 | 1,413,610 | 3,559,936 |
| 20-Day Average Volume | 1,781,376 | 2,461,171 | 2,930,080 | 7,582,063 | 13,316,921 |
| Previous Close | 17.56 | 208.45 | 388.16 | 148.95 | 62.37 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 14.79 | 200.06 | 372.37 | 149.67 | 60.22 |
| 20-Day Raw Stochastic | 98.37% | 69.53% | 89.97% | 56.19% | 95.89% |
| 20-Day Relative Strength | 62.94 | 58.04 | 64.08 | 59.24 | 67.89 |
| Weighted Alpha | +145.95 | +40.22 | +30.45 | +38.04 | +18.08 |
| Today's Opinion | 88% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 72% Buy | 100% Buy | 100% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 56% Buy | 88% Buy | 100% Buy | 100% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.27% since 02/23/26 | -0.53% since 02/23/26 | +1.70% since 02/23/26 | -0.07% since 02/23/26 | +2.14% since 02/23/26 |
| Low | 16.75 on 02/24/26 | 202.64 on 02/26/26 | 374.25 on 02/26/26 | 143.09 on 02/26/26 | 60.65 on 02/26/26 |
| High | 18.24 on 03/02/26 | 209.93 on 02/27/26 | 391.14 on 03/02/26 | 150.15 on 03/02/26 | 62.89 on 03/02/26 |
| 1-Month | |||||
| %Chg | +36.49% since 02/02/26 | +8.19% since 02/02/26 | +11.95% since 02/02/26 | +4.78% since 02/02/26 | +11.93% since 02/02/26 |
| Low | 12.11 on 02/04/26 | 183.63 on 02/03/26 | 338.59 on 02/03/26 | 142.03 on 02/03/26 | 55.49 on 02/03/26 |
| High | 18.24 on 03/02/26 | 212.71 on 02/18/26 | 391.14 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | +32.51% since 12/02/25 | +13.04% since 12/02/25 | +14.04% since 12/02/25 | +20.83% since 12/02/25 | +29.66% since 12/02/25 |
| Low | 12.11 on 02/04/26 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 49.42 on 12/03/25 |
| High | 19.11 on 12/08/25 | 212.71 on 02/18/26 | 391.14 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +54.65% since 09/02/25 | +27.10% since 09/02/25 | +34.49% since 09/02/25 | +32.84% since 09/02/25 | +31.96% since 09/02/25 |
| Low | 9.65 on 11/05/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 19.11 on 12/08/25 | 212.71 on 02/18/26 | 391.14 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,453,740 | 323,286,752 | 209,244,640 | 184,909,664 | 127,014,880 |
| Shares Outstanding, K | 82,787 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 43,270,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -130,870,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 970,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -59,730,000 | 2,326,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 1.76 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.85 on 11/05/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 03/04/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.73 | 17.76 | 18.28 | 10.14 |